Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach. (COPD_CPilates)

December 4, 2025 updated by: Cristiana Marques, University of Trás-os-Montes and Alto Douro

Effect of a Clinical Pilates Programme on Individuals With Gold A COPD on Lung Function, Motor Performance, Chest Mobility, Sleep and Physical Activity, and Health-related Quality of Life: an Interactive Approach Between Rehabilitation Nursing and Sports Sciences.

The main objective of this study is to evaluate the effects of a Clinical Pilates-based exercise programme on chest mobility, lung function, motor performance, physical activity levels, sleep quality and Health-Related Quality of Life (HRQoL) in individuals with Gold A COPD. Based on our research question, 'What is the effect of a Clinical Pilates programme on thoracic mobility, pulmonary function, motor performance, physical activity levels, sleep quality, and HRQoL in people with Gold A COPD?', we propose the following research hypotheses:

H1: The Clinical Pilates programme contributed to improved thoracic mobility in people with Gold A COPD.

H2: The Clinical Pilates programme contributed to improved lung function in people with Gold A COPD.

H3: The Clinical Pilates programme positively influences the motor performance of people with Gold A COPD.

H4: The Clinical Pilates programme positively influences the physical activity levels of people with COPD Gold A.

H5: The Clinical Pilates programme positively influences the sleep quality of people with COPD Gold A.

H6: The Clinical Pilates programme contributes to improving the HRQoL levels of people with COPD Gold A.

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Guimarães, Portugal, 4800
        • Unidade de Cuidados na Comunidade de Guimarães

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Anyone diagnosed with COPD at GOLD stage A, duly identified in SClínico, registered with the USF and residing in the geographical area covered by the Guimarães UCC, whose participation is validated by their family doctor. Inclusion in the study implies participation in at least 60% of the programme sessions, namely 10.

Exclusion Criteria:

  • People with a history of exacerbation of the disease less than 4 weeks ago, as the guidelines of the European Respiratory Society and the American Thoracic Society (2017) make a conditional recommendation on pulmonary rehabilitation after exacerbation and recommend waiting at least 3 weeks, severe osteoarticular limitation that prevents physical exercise, psychiatric illness or severe cognitive dysfunction, unstable comorbidities such as unstable ischaemic disease or decompensated heart failure, and exercise-induced hypoxemia refractory to oxygen administration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Clinical Pilates Group (CPG)
Group of individuals with ongoing rehabilitation nursing consultations who participate in the CP programme consisting of 16 sessions of 60 minutes each.
8-week programme with face-to-face sessions twice a week, lasting approximately 60 minutes per session, using equipment such as soft balls and elastic bands.
No Intervention: Control Group (CG)
Group that only underwent follow-up rehabilitation nursing consultations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing, on thoracic mobility in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

Chirometric tests of the Thorax (Lanza et al., 2013).

  • The person stands with their hands on their hips, chest bare, with the investigator in front of them;
  • A tape measure is placed over the patient's rib cage in the axillary region;
  • The zero point of the tape measure is fixed in the anterior region of the chest at each level: axillary, with the tape passing through the axillary fold, and xiphoid, with the tape fixed to the xiphoid process. The other end of the tape goes around the chest and is pulled by the examiner over this fixed point, exerting as little pressure as possible on the person's body (the tape is adjusted but not tightened, ensuring that the contour of the soft tissues remains unchanged).
  • The person is asked to take a maximum breath in, followed by a maximum breath out, holding each for at least 2 seconds.
  • The measurement (cm) is recorded at the end of the breath out and the breath in.
  • The measurement is repeated.
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on pulmonary function in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

Peak expiratory flow - Peak Flow (Miler et al., 2005).

  • The person sits with their neck in a neutral position, looking straight ahead;
  • They hold the Peak Flow meter and place it close to their mouth (ensuring that the indicator needle is set at 0);
  • The person takes a deep breath, places the Peak Flow in their mouth, between their teeth and with their tongue under the mouthpiece, and blows as hard as possible without pausing;
  • The highest value of at least three readings is recorded, with only readings that do not differ by more than 20L/min being considered;
  • Invalidate the result in case of excess saliva in the mouthpiece or coughing during exhalation;
  • The measurement range is between 50-800 L/min in accordance with the applicable standard ISO 23747:2015.
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on motor performance in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

One-minute sit-to-stand test (Vaidya et al., 2016) and modified Borg scale (Borg, 1982).

  • The person sits on a chair leaning against the wall, with knees and hips bent at 90º, feet flat on the floor and hands resting on their legs;
  • The person is asked to stand up and sit down from the chair as quickly as possible without support for one minute.
  • The number of repetitions is counted.
  • At the end, the 'Modified Borg Scale' is applied.
  • The scale is placed in front of the person and they are asked to rate the degree of dyspnoea they perceive.
  • The rating ranges from 0 to 10, with 0 being 'No shortness of breath' and 10 being 'Maximum shortness of breath'.
  • The person indicates the number corresponding to the dyspnoea they feel.
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on physical activity levels in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

Actigraph® GT3X+ accelerometer. The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend.

The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds.

A record sheet will be provided to indicate the times when the accelerometer is put on and taken off.

The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory.

Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on sleep quality in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend.

The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds.

A record sheet will be provided to indicate the times when the accelerometer is put on and taken off.

The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory.

Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on Health-related quality of life (HRQoL) in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

EQ-5D-5L (Ferreira et al., 2023).

Likert scale (1 to 5) self-assessment that considers 5 domains:

  • Mobility: from 'I have no mobility problems' to 'I am unable to walk';
  • Personal care: 'I have no problems washing or dressing myself' to 'I am unable to wash or dress myself';
  • Usual activities (e.g. domestic, leisure or family activities): 'I have no problem performing my usual activities' to 'I am unable to perform my usual activities';
  • Pain/Discomfort: 'I have no pain or discomfort' to 'I have extreme pain or discomfort';
  • Anxiety/Depression: 'I am not anxious and/or depressed' to 'I am extremely anxious and/or depressed';
  • Visual scale from 0 to 100, where 0 is 'worst health imaginable' and 100 is 'best health imaginable.' The person is asked to place an X on the scale to indicate how they feel about their health at the moment.
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2024

Primary Completion (Actual)

November 11, 2025

Study Completion (Estimated)

July 24, 2026

Study Registration Dates

First Submitted

November 16, 2025

First Submitted That Met QC Criteria

December 4, 2025

First Posted (Actual)

December 5, 2025

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD (Chronic Obstructive Pulmonary Disease)

Clinical Trials on Clinical Pilates for people with COPD Gold A.

Subscribe